![]() |
Volumn 36, Issue 4, 1993, Pages 267-273
|
Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
a
d
NONE
|
Author keywords
Breast cancer; Chimeric; Colon cancer; Monoclonal antibody; Non small cell lung cancer; Phase I trial
|
Indexed keywords
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CHL 6;
UNCLASSIFIED DRUG;
ADULT;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ARTICLE;
BREAST CANCER;
CANCER PAIN;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED STUDY;
FEMALE;
HEADACHE;
HUMAN;
HYPOTENSION;
INFLUENZA;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
MALE;
NAUSEA;
PHARMACOKINETICS;
PRIORITY JOURNAL;
VOMITING;
ADULT;
AGED;
ANIMAL;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
BREAST NEOPLASMS;
CARCINOMA;
CARCINOMA, NON-SMALL-CELL LUNG;
CHIMERIC PROTEINS;
COLONIC NEOPLASMS;
COMPLEMENT 3;
COMPLEMENT 4;
HUMAN;
IMMUNOTHERAPY;
LUNG NEOPLASMS;
MICE;
MIDDLE AGE;
|
EID: 0027477134
PISSN: 03407004
EISSN: 14320851
Source Type: Journal
DOI: 10.1007/BF01740909 Document Type: Article |
Times cited : (60)
|
References (19)
|